Eyal, N. (2020). Why Challenge Trials of SARS‐CoV‐2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events. Ethics Hum Res.
Styl cytowania ChicagoEyal, Nir. "Why Challenge Trials of SARS‐CoV‐2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events." Ethics Hum Res 2020.
Styl cytowania MLAEyal, Nir. "Why Challenge Trials of SARS‐CoV‐2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events." Ethics Hum Res 2020.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..